PillInfluenzinum (2022-2023), Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6a, Human Herpesvirus 6b, Cytomegalovirus Nosode, Hepatitis B Nosode, Adenoviren Nosode, Epstein-Barr Virus Nosode
Brands: Vir Combination · Hepatitis B Virus + Human Adenovirus B Serotype 7 Strain 55142 Antigen + Human Adenovirus E Serotype 4 Strain Cl-68578 Antigen + Human Herpesvirus 1 + Human Herpesvirus 2 + Human Herpesvirus 4 + Human Herpesvirus 5 + Human Herpesvirus 6 + Influenza A Virus A/Darwin/9/2021 Ivr-228 (H3n2) Antigen (Uv, Formaldehyde Inactivated) + Influenza A Virus A/Victoria/2570/2019 Ivr-215 (H1n1) Antigen (Uv, Formaldehyde Inactivated) + Influenza B Virus B/Austria/1359417/2021 Bvr-26 Antigen (Uv, Formaldehyde Inactivated) + Influenza B Virus B/Phuket/3073/2013 Antigen (Uv, Formaldehyde Inactivated)
0 active makers
soon
soon
soon
soon
Medicaid dispensing volume
No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.
Who makes it0 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Deseret Biologicals, Inc | unknown | 1 | EXITED 2028 |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.